These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 27247842)

  • 1. Is Metabolic Syndrome On the Radar? Improving Real-Time Detection of Metabolic Syndrome and Physician Response by Computerized Scan of the Electronic Medical Record.
    Lui K; Randhawa G; Totten V; Smith AE; Raese J
    Prim Care Companion CNS Disord; 2016; 18(1):. PubMed ID: 27247842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic Syndrome and Cardiovascular Risk in People Treated with Long-Acting Injectable Antipsychotics.
    Sanchez-Martinez V; Romero-Rubio D; Abad-Perez MJ; Descalzo-Cabades MA; Alonso-Gutierrez S; Salazar-Fraile J; Montagud V; Facila L
    Endocr Metab Immune Disord Drug Targets; 2018; 18(4):379-387. PubMed ID: 29165095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of a computerized best practice alert system in an outpatient setting on metabolic monitoring in patients on second-generation antipsychotics.
    Cohen S; Bostwick JR; Marshall VD; Kruse K; Dalack GW; Patel P
    J Clin Pharm Ther; 2020 Dec; 45(6):1398-1404. PubMed ID: 32767599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome and the risk of coronary heart disease in 367 patients treated with second-generation antipsychotic drugs.
    Correll CU; Frederickson AM; Kane JM; Manu P
    J Clin Psychiatry; 2006 Apr; 67(4):575-83. PubMed ID: 16669722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of melatonin in reducing second-generation antipsychotic metabolic effects: A double blind controlled clinical trial.
    Agahi M; Akasheh N; Ahmadvand A; Akbari H; Izadpanah F
    Diabetes Metab Syndr; 2018; 12(1):9-15. PubMed ID: 28847468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic syndrome and atypical antipsychotics: Possibility of prediction and control.
    Franch Pato CM; Molina Rodríguez V; Franch Valverde JI
    Rev Psiquiatr Salud Ment; 2017; 10(1):38-44. PubMed ID: 27939025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic screen and intervene: improving mental health inpatient metabolic monitoring.
    Viglione L; Short BL
    Australas Psychiatry; 2021 Jun; 29(3):289-293. PubMed ID: 32615781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The metabolic syndrome in an Italian psychiatric sample: a retrospective chart review of inpatients treated with antipsychotics.
    Santini I; Stratta P; D'Onofrio S; De Lauretis I; Santarelli V; Pacitti F; Rossi A
    Riv Psichiatr; 2016; 51(1):37-42. PubMed ID: 27030348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnitude of metabolic syndrome and its predictors among patients on second-generation antipsychotic drugs at six psychiatry clinics and mental hospitals, in Addis Ababa, Ethiopia, 2019; Multicenter cross-sectional study.
    Amogne G; Alemu T; Tadesse T; Mullu A
    Diabetes Metab Syndr; 2021; 15(4):102187. PubMed ID: 34214901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signs and symptoms associated with the metabolic syndrome in psychiatric inpatients receiving antipsychotics: a retrospective chart review.
    Goethe JW; Szarek BL; Caley CF; Woolley SB
    J Clin Psychiatry; 2007 Jan; 68(1):22-8. PubMed ID: 17284126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Who is responsible for metabolic screening for mental health clients taking antipsychotic medications?
    Ward T; Wynaden D; Heslop K
    Int J Ment Health Nurs; 2018 Feb; 27(1):196-203. PubMed ID: 28093900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic testing rates in 3 state Medicaid programs after FDA warnings and ADA/APA recommendations for second-generation antipsychotic drugs.
    Morrato EH; Druss B; Hartung DM; Valuck RJ; Allen R; Campagna E; Newcomer JW
    Arch Gen Psychiatry; 2010 Jan; 67(1):17-24. PubMed ID: 20048219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a computer-based intervention to enhance metabolic monitoring in psychiatry inpatients treated with second-generation antipsychotics.
    DelMonte MT; Bostwick JR; Bess JD; Dalack GW
    J Clin Pharm Ther; 2012 Dec; 37(6):668-73. PubMed ID: 22845616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic monitoring and management among clozapine users.
    Tso G; Kumar P; Jayasooriya T; Kisely S; Siskind D
    Australas Psychiatry; 2017 Feb; 25(1):48-52. PubMed ID: 27590080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loxapine for Reversal of Antipsychotic-Induced Metabolic Disturbances: A Chart Review.
    Jain S; Andridge R; Hellings JA
    J Autism Dev Disord; 2016 Apr; 46(4):1344-53. PubMed ID: 26687568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of a metabolic screening bundle on rates of screening for metabolic syndrome in a psychiatry resident outpatient clinic.
    Wiechers IR; Viron M; Stoklosa J; Freudenreich O; Henderson DC; Weiss A
    Acad Psychiatry; 2012 Mar; 36(2):118-21. PubMed ID: 22532201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic risk status and second-generation antipsychotic drug selection: a retrospective study of commercially insured patients.
    Morrato EH; Cuffel B; Newcomer JW; Lombardo I; Kamat S; Barron J
    J Clin Psychopharmacol; 2009 Feb; 29(1):26-32. PubMed ID: 19142103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Metabolic side effects of risperidone in early onset schizophrenia].
    Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
    Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic Side Effects in Patients Using Atypical Antipsychotic Medications During Hospitalization.
    Dikeç G; Arabaci LB; Uzunoglu GB; Mizrak SD
    J Psychosoc Nurs Ment Health Serv; 2018 Apr; 56(4):28-37. PubMed ID: 29328360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.